Document 2302
 DOCN  M94A2302
 TI    Evaluation on a year period of antiretroviral drug bank for HIV/AIDS
       patients of public health services in Chile.
 DT    9412
 AU    Bustos P; Child R; Toro L
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):335 (abstract no. PC0275). Unique
       Identifier : AIDSLINE ICA10/94370273
 AB    OBJECTIVES: To evaluate the results obtained with the Anti retroviral
       drugs Bank, set up by the National Commission of AIDS of Chile with the
       physicians treating HIV/AIDS patients. This in order to increase the
       quality of life of people living with HIV/AIDS and the collaboration
       between health authorities, National Commission of AIDS, and clinicians
       involved in AIDS. METHOD: In December 1992 a Protocol of Antiretroviral
       Therapy for Adults was set up by physicians that take care of HIV/AIDS
       patients and the National Commission of AIDS from the Ministry of
       Health. This protocol includes: conditions for treatment (CD4 < 300 x
       mm3), conditions for exclusion (before or after the beginning),
       laboratory studies (X ray, serologies, PPD skin test), periodic clinical
       controls (monthly), interventions (500mg/d in 3-5 sumministration),
       changes of treatment (reduction-suspension), chemoprophilaxis, other
       aspects such as pregnancy or interaction with other medicines. AZT
       distribution was made all over the country through the public health
       services. RESULTS: After a year of accomplishment there was an increase
       of 88.2% in the number of patients treated with Zidovudine (AZT)
       therapy. In the latest '93 we also began supplying ddI and ddC as
       substitution treatments. This programme covers the 86% of HIV/AIDS
       patients that the Public Health system takes care. TABULAR DATA, SEE
       ABSTRACT VOLUME. CONCLUSIONS: Health care workers must work together
       with other sectors--including the economical one, in order to increase
       efficiency and to obtain the access to expensive treatments providing
       HIV/AIDS patients a better quality of medical care and quality of life.
 DE    Acquired Immunodeficiency Syndrome/*DRUG THERAPY  Adult  Antiviral
       Agents/*THERAPEUTIC USE  Didanosine/THERAPEUTIC USE  Human  HIV
       Infections/*DRUG THERAPY  *Medical Indigency  Patient Care Team  *Public
       Health  Quality of Life  Zalcitabine/THERAPEUTIC USE
       Zidovudine/THERAPEUTIC USE  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).